Orthostatic Hypotension and Parkinson's disease
Thursday 10 December 2020, 5-6pm AEDT
Presented by: Dr Sam Bolitho & Rachael McKinnon
Neurogenic orthostatic hypotension is a common and disabling non-motor symptom affecting people with Parkinson’s disease (PwP). This is related to dysautonomia which is an impairment in the function of the autonomic nervous system. Symptomatic orthostatic hypotension can predispose PwP to falls and accidents, and can impact greatly upon a PwP’s Health Related Quality of Life.
It is estimated that between 30-60% of PwP will have orthostatic hypotension which is defined as low blood pressure (SBP < 20mmHg) on standing within 3 minutes of arising from a supine position and is not due to cardiac or low blood volume reasons. The goal to treatment is challenging, and may not be to normalize standing BP, but to reduce symptom burden 
and improve quality of life.
This session will cover:
- A Case study of a PwP and Orthostatic Hypotension
- Pathophysiology and prevalence of nOh in Parkinson’s
- Non-pharmacological and pharmacology interventions
- The perils of withdrawing ant-Parkinson's medications
Key learnings:
- Review and identification of the risk oforthostatic hypotension when undertaking an assessment of a PwP
- Monitoring blood pressures of PwP lying and standing 1 minute and 3 minutes
- Understanding of paradoxical supine hypertension
CPD Information:
Webinar attendance and completion of the reflection tool can be included
in your Continuing Professional Development (CPD) portfolio. A
certificate will be issued after the webinar.
Zoom details will be emailed to you before the webinar.
Price:
ANNA Members = Free (Login to register)
Non Members = $25.00 (create a new account to register)
Important Note!:
Registrations are not complete, until the checkout process is completed.
Click the 'Register Myself' button, then don't forget to 'Proceed to Checkout' at the bottom of the page!
Proudly Sponsored by
